The adenosine A2A receptor in triple-negative breast cancer: molecular mechanisms and therapeutic implications.

Saved in:
Bibliographic Details
Title: The adenosine A2A receptor in triple-negative breast cancer: molecular mechanisms and therapeutic implications.
Authors: Sharma D; Symbiosis School of Biological Sciences (SSBS), Symbiosis International (Deemed University), Gram Lavale, Taluka Mulshi, Pune, Maharashtra, 412115, India.; School of Medicine, Pharmacy and Biosciences, Aston University, Aston Triangle, Birmingham, B4 7ET, UK., Sisodiya S; Symbiosis School of Biological Sciences (SSBS), Symbiosis International (Deemed University), Gram Lavale, Taluka Mulshi, Pune, Maharashtra, 412115, India.; ICMR-National Institute of Cancer Prevention and Research (ICMR-NICPR), Noida, India., Hussain S; ICMR-National Institute of Cancer Prevention and Research (ICMR-NICPR), Noida, India., Vaidya A; Symbiosis School of Biological Sciences (SSBS), Symbiosis International (Deemed University), Gram Lavale, Taluka Mulshi, Pune, Maharashtra, 412115, India., Spickett CM; School of Medicine, Pharmacy and Biosciences, Aston University, Aston Triangle, Birmingham, B4 7ET, UK., Sanchez-Aranguren L; School of Medicine, Pharmacy and Biosciences, Aston University, Aston Triangle, Birmingham, B4 7ET, UK., Mishra N; Symbiosis School of Biological Sciences (SSBS), Symbiosis International (Deemed University), Gram Lavale, Taluka Mulshi, Pune, Maharashtra, 412115, India. neetu.mishra@ssbs.edu.in.
Source: Discover oncology [Discov Oncol] 2026 Jun 16. Date of Electronic Publication: 2026 Jun 16.
Publication Type: Journal Article; Review
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol
Database: MEDLINE Ultimate
Description
ISSN:2730-6011
DOI:10.1007/s12672-026-05418-x